| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | abnormal respiratory system morphology | 3.22e-06 | 1027 | 29 | 11 | MP:0002132 | |
| MousePheno | abnormal motor neuron morphology | 1.33e-05 | 151 | 29 | 5 | MP:0000937 | |
| MousePheno | abnormal lung morphology | 1.59e-05 | 767 | 29 | 9 | MP:0001175 | |
| MousePheno | abnormal spinal cord morphology | 1.89e-05 | 278 | 29 | 6 | MP:0000955 | |
| MousePheno | abnormal spinal cord grey matter morphology | 3.18e-05 | 181 | 29 | 5 | MP:0008503 | |
| MousePheno | mandible hypoplasia | 4.60e-05 | 34 | 29 | 3 | MP:0000460 | |
| MousePheno | abnormal Meckel's cartilage morphology | 8.12e-05 | 41 | 29 | 3 | MP:0005587 | |
| MousePheno | abnormal tongue morphology | 9.73e-05 | 118 | 29 | 4 | MP:0000762 | |
| MousePheno | decreased submandibular gland size | 1.15e-04 | 8 | 29 | 2 | MP:0009520 | |
| MousePheno | abnormal choroid plexus morphology | 1.30e-04 | 48 | 29 | 3 | MP:0000820 | |
| MousePheno | abnormal tela choroidea morphology | 1.30e-04 | 48 | 29 | 3 | MP:0013306 | |
| MousePheno | abnormal cranial cartilage morphology | 1.47e-04 | 50 | 29 | 3 | MP:0030464 | |
| MousePheno | pulmonary hypoplasia | 1.85e-04 | 54 | 29 | 3 | MP:0001178 | |
| MousePheno | facial bone hypoplasia | 2.18e-04 | 57 | 29 | 3 | MP:0030386 | |
| MousePheno | small maxilla | 2.41e-04 | 59 | 29 | 3 | MP:0004540 | |
| MousePheno | maxilla hypoplasia | 2.71e-04 | 12 | 29 | 2 | MP:0000457 | |
| MousePheno | cleft palate | 2.88e-04 | 289 | 29 | 5 | MP:0000111 | |
| MousePheno | oral cleft | 2.98e-04 | 291 | 29 | 5 | MP:0021164 | |
| MousePheno | persistent truncus arteriosus | 3.52e-04 | 67 | 29 | 3 | MP:0002633 | |
| MousePheno | abnormal aorticopulmonary septum morphology | 3.67e-04 | 68 | 29 | 3 | MP:0010650 | |
| MousePheno | aorticopulmonary septal defect | 3.67e-04 | 68 | 29 | 3 | MP:0010651 | |
| MousePheno | abnormal palate morphology | 4.67e-04 | 321 | 29 | 5 | MP:0003755 | |
| MousePheno | abnormal striatum morphology | 4.90e-04 | 75 | 29 | 3 | MP:0004077 | |
| MousePheno | abnormal salivary gland morphology | 5.30e-04 | 77 | 29 | 3 | MP:0000613 | |
| MousePheno | abnormal innervation | 6.38e-04 | 193 | 29 | 4 | MP:0002184 | |
| MousePheno | neonatal lethality, complete penetrance | 6.77e-04 | 534 | 29 | 6 | MP:0011087 | |
| MousePheno | abnormal truncus arteriosus septation | 6.83e-04 | 84 | 29 | 3 | MP:0010454 | |
| MousePheno | abnormal nervous system development | 7.12e-04 | 1257 | 29 | 9 | MP:0003861 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | 7.63e-04 | 1269 | 29 | 9 | MP:0011111 | |
| MousePheno | small uterus | 8.90e-04 | 92 | 29 | 3 | MP:0002637 | |
| MousePheno | abnormal merocrine gland morphology | 1.04e-03 | 97 | 29 | 3 | MP:0013544 | |
| MousePheno | abnormal respiration | 1.22e-03 | 598 | 29 | 6 | MP:0001943 | |
| Domain | - | 2.54e-03 | 40 | 35 | 2 | 4.10.1000.10 | |
| Domain | SET | 3.35e-03 | 46 | 35 | 2 | SM00317 | |
| Domain | ZnF_C3H1 | 3.65e-03 | 48 | 35 | 2 | SM00356 | |
| Domain | zf-CCCH | 3.80e-03 | 49 | 35 | 2 | PF00642 | |
| Domain | SET_dom | 3.95e-03 | 50 | 35 | 2 | IPR001214 | |
| Domain | SET | 3.95e-03 | 50 | 35 | 2 | PS50280 | |
| Domain | Znf_CCCH | 5.28e-03 | 58 | 35 | 2 | IPR000571 | |
| Domain | ZF_C3H1 | 5.28e-03 | 58 | 35 | 2 | PS50103 | |
| Domain | zf-C3HC4 | 8.30e-03 | 223 | 35 | 3 | PF00097 | |
| Pubmed | 1.59e-05 | 486 | 39 | 6 | 20936779 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 18025162 | ||
| Pubmed | 2.86e-05 | 808 | 39 | 7 | 20412781 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 4.29e-05 | 861 | 39 | 7 | 36931259 | |
| Pubmed | Regulation of GATA-3 expression during CD4 lineage differentiation. | 5.48e-05 | 10 | 39 | 2 | 21357543 | |
| Pubmed | 8.03e-05 | 12 | 39 | 2 | 21945074 | ||
| Pubmed | Gene expression changes in the secondary palate and mandible of Prdm16(-/-) mice. | 9.48e-05 | 13 | 39 | 2 | 23149718 | |
| Pubmed | Role of topoisomerase IIbeta in the expression of developmentally regulated genes. | 1.46e-04 | 16 | 39 | 2 | 16923961 | |
| Pubmed | 1.85e-04 | 18 | 39 | 2 | 29899135 | ||
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 1.96e-04 | 100 | 39 | 3 | 25807483 | |
| Pubmed | 2.30e-04 | 20 | 39 | 2 | 24385915 | ||
| Pubmed | Directed migration of cortical interneurons depends on the cell-autonomous action of Sip1. | 2.54e-04 | 21 | 39 | 2 | 23312517 | |
| Pubmed | Resolving organoid brain region identities by mapping single-cell genomic data to reference atlases. | 2.79e-04 | 22 | 39 | 2 | 33711282 | |
| Pubmed | 2.79e-04 | 22 | 39 | 2 | 33821423 | ||
| Pubmed | Nkx6.1 controls migration and axon pathfinding of cranial branchio-motoneurons. | 3.33e-04 | 24 | 39 | 2 | 14534138 | |
| Pubmed | Loss of Gsx1 and Gsx2 function rescues distinct phenotypes in Dlx1/2 mutants. | 3.62e-04 | 25 | 39 | 2 | 23042297 | |
| Pubmed | 3.62e-04 | 25 | 39 | 2 | 29475039 | ||
| Pubmed | 4.23e-04 | 27 | 39 | 2 | 20081190 | ||
| Pubmed | BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. | 4.55e-04 | 28 | 39 | 2 | 19224984 | |
| Pubmed | 4.55e-04 | 28 | 39 | 2 | 23103586 | ||
| Pubmed | Genetic mapping of eight SH3 domain genes on seven mouse chromosomes. | 4.55e-04 | 28 | 39 | 2 | 10087302 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 4.87e-04 | 908 | 39 | 6 | 19274049 | |
| Pubmed | 4.88e-04 | 29 | 39 | 2 | 26097038 | ||
| Pubmed | 5.58e-04 | 31 | 39 | 2 | 24014668 | ||
| Pubmed | c-Jun is required for the specification of joint cell fates. | 5.58e-04 | 31 | 39 | 2 | 23475960 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 5.70e-04 | 341 | 39 | 4 | 32971831 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 6.17e-04 | 148 | 39 | 3 | 32538781 | |
| Pubmed | Activation of beta-catenin signaling programs embryonic epidermis to hair follicle fate. | 6.33e-04 | 33 | 39 | 2 | 18480165 | |
| Pubmed | 6.66e-04 | 152 | 39 | 3 | 38360978 | ||
| Pubmed | 6.72e-04 | 34 | 39 | 2 | 20181579 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 6.83e-04 | 358 | 39 | 4 | 32460013 | |
| Pubmed | β-Catenin regulates endocardial cushion growth by suppressing p21. | 7.12e-04 | 35 | 39 | 2 | 37385754 | |
| Pubmed | 7.96e-04 | 37 | 39 | 2 | 22432025 | ||
| Pubmed | 7.96e-04 | 37 | 39 | 2 | 29044125 | ||
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 9.37e-04 | 171 | 39 | 3 | 20201926 | |
| Pubmed | 9.77e-04 | 41 | 39 | 2 | 19878569 | ||
| Cytoband | 22q12.2 | 1.13e-03 | 58 | 39 | 2 | 22q12.2 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 9.23e-04 | 34 | 24 | 2 | 487 | |
| GeneFamily | Zinc fingers CCCH-type | 9.78e-04 | 35 | 24 | 2 | 73 | |
| GeneFamily | HOXL subclass homeoboxes | 2.15e-03 | 52 | 24 | 2 | 518 | |
| GeneFamily | Ring finger proteins | 5.56e-03 | 275 | 24 | 3 | 58 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.91e-02 | 161 | 24 | 2 | 593 | |
| Coexpression | GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_UP | 4.00e-07 | 199 | 38 | 6 | M7885 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 5.56e-06 | 177 | 38 | 5 | M39245 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.56e-05 | 173 | 39 | 4 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 175 | 39 | 4 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 175 | 39 | 4 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 176 | 39 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 189 | 39 | 4 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 189 | 39 | 4 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 189 | 39 | 4 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 189 | 39 | 4 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-05 | 190 | 39 | 4 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.26e-05 | 190 | 39 | 4 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-05 | 190 | 39 | 4 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-05 | 190 | 39 | 4 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 191 | 39 | 4 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-05 | 192 | 39 | 4 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-05 | 192 | 39 | 4 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.35e-05 | 192 | 39 | 4 | e79f2253e084a9ab9afcaf7ec42a5012ade42d36 | |
| ToppCell | tumor_Lung-Endothelial_cells-Stalk-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.50e-05 | 195 | 39 | 4 | 56f88ce95495260360bf08f9c76cc36e395dc6a9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 196 | 39 | 4 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 196 | 39 | 4 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass | 2.76e-05 | 200 | 39 | 4 | 3813fa1ee1462ba83fd8b6253070f46f0b063084 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-05 | 98 | 39 | 3 | 95162072f3afc95e46f29db3d79ebd930bc09726 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.66e-04 | 122 | 39 | 3 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 129 | 39 | 3 | e7a15f98c3e6e4ee317e21958be3e413e3acd101 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-maDC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.22e-04 | 153 | 39 | 3 | b03375c54aa701817c0fc2c3fef32b870169e697 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.22e-04 | 153 | 39 | 3 | 18bd770a18e642581a6df144d47184c1ac383713 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.41e-04 | 156 | 39 | 3 | 0f2147abcf31a26ee5b2f4d8c5d72232612a33f0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.41e-04 | 156 | 39 | 3 | cb87f12443fdc5538b856f765fcbac9406044e10 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-04 | 157 | 39 | 3 | 432b8719a8afd289cf48068e12c26a349d753fcc | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.67e-04 | 160 | 39 | 3 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.74e-04 | 161 | 39 | 3 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-04 | 164 | 39 | 3 | b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-04 | 164 | 39 | 3 | 78de403446fe0eb375c82ff1832cc5fbb8e20afa | |
| ToppCell | droplet-Fat-Scat-21m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-04 | 165 | 39 | 3 | 3f0c2486ea357d10dad0b703cf75cc29bdd5b5cf | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.09e-04 | 166 | 39 | 3 | ceb0a48c0d853448fd45ac31dde046df9a178571 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.09e-04 | 166 | 39 | 3 | a867dbcb36f7449062bd3d2293c67b67d14e2f99 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.16e-04 | 167 | 39 | 3 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.38e-04 | 170 | 39 | 3 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-04 | 173 | 39 | 3 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-04 | 173 | 39 | 3 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 4.61e-04 | 173 | 39 | 3 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-04 | 173 | 39 | 3 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.77e-04 | 175 | 39 | 3 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-04 | 175 | 39 | 3 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-04 | 175 | 39 | 3 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-04 | 175 | 39 | 3 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-04 | 176 | 39 | 3 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-04 | 176 | 39 | 3 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.93e-04 | 177 | 39 | 3 | 88403b055eb9fdf96e4695fb6e0d78179e30a1e3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.93e-04 | 177 | 39 | 3 | 8903aeaab61abd81a148ea623038c5114b8a183b | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 5.09e-04 | 179 | 39 | 3 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 5.09e-04 | 179 | 39 | 3 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.09e-04 | 179 | 39 | 3 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 5.18e-04 | 180 | 39 | 3 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | VE-matDC-|VE / Condition, Cell_class and T cell subcluster | 5.26e-04 | 181 | 39 | 3 | 6252184ef098b911df50be4fe1b5565849a5b6b8 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 5.26e-04 | 181 | 39 | 3 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 181 | 39 | 3 | 6d1f1ad35778a2a227f966f11f6edd8e89452576 | |
| ToppCell | VE-matDC|VE / Condition, Cell_class and T cell subcluster | 5.26e-04 | 181 | 39 | 3 | 982fd96ef75bc9ab2c2f4970c01b76ba7a164871 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 182 | 39 | 3 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.35e-04 | 182 | 39 | 3 | 728a2152c166551ac229370c0900fe2bc426ea9b | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 182 | 39 | 3 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 182 | 39 | 3 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-04 | 182 | 39 | 3 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 5.43e-04 | 183 | 39 | 3 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-04 | 183 | 39 | 3 | a0a3e4d07ac73dbbb1e019fd11e88ccffe6cf2ca | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-04 | 183 | 39 | 3 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-04 | 183 | 39 | 3 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-04 | 183 | 39 | 3 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-04 | 183 | 39 | 3 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | Pericytes-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 5.52e-04 | 184 | 39 | 3 | 3d2d55d0f22874be21665ab37da710482f77fc36 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.52e-04 | 184 | 39 | 3 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-04 | 184 | 39 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.52e-04 | 184 | 39 | 3 | 590fb32bb1f348ea5fa2aece30ebe1e212512991 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-04 | 185 | 39 | 3 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-04 | 186 | 39 | 3 | 11929e36d8c9b4c4bc2f5e912f139f474f91ab00 | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 5.69e-04 | 186 | 39 | 3 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 5.78e-04 | 187 | 39 | 3 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-04 | 188 | 39 | 3 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-04 | 188 | 39 | 3 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.87e-04 | 188 | 39 | 3 | 116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-04 | 188 | 39 | 3 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-04 | 189 | 39 | 3 | fac5c291a9a87418bb0878c3d624829bdbf1f428 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-04 | 189 | 39 | 3 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | ASK452-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.97e-04 | 189 | 39 | 3 | f5dc500f77f04a110dd4a65cf4c03068a495dbdb | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 5.97e-04 | 189 | 39 | 3 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 6.06e-04 | 190 | 39 | 3 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 6.15e-04 | 191 | 39 | 3 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-04 | 191 | 39 | 3 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-04 | 191 | 39 | 3 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 6.15e-04 | 191 | 39 | 3 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 6.15e-04 | 191 | 39 | 3 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.15e-04 | 191 | 39 | 3 | a05e9a7eb137d804570dd7d8905975d735738767 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-04 | 191 | 39 | 3 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-04 | 191 | 39 | 3 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-04 | 191 | 39 | 3 | 65083daf317f66556dc047eb19297dcbe9c70299 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-04 | 191 | 39 | 3 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | IPF-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 6.24e-04 | 192 | 39 | 3 | 9b06c7336624ef21f8e5393725b56038a8028e57 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.24e-04 | 192 | 39 | 3 | 2802fae55683345ff94a1ecf73b6fbee4f17481e | |
| ToppCell | ASK452-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.24e-04 | 192 | 39 | 3 | 8269b88ff6073a908f547fcc7c5941f2e8289694 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-04 | 192 | 39 | 3 | 24e2f15f5767a97eb3b389922bcfd7b13805e1ce | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.34e-04 | 193 | 39 | 3 | 4aa976b596830b585e8d9c808d5072ed23d13a7c | |
| Drug | trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A | 1.70e-08 | 179 | 38 | 7 | 331_DN | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; HL60; HT_HG-U133A | 1.70e-05 | 194 | 38 | 5 | 2485_DN | |
| Drug | Iopanoic acid [96-83-3]; Up 200; 7uM; HL60; HT_HG-U133A | 1.70e-05 | 194 | 38 | 5 | 2965_UP | |
| Drug | Epiandrosterone [481-29-8]; Down 200; 13.8uM; HL60; HT_HG-U133A | 1.75e-05 | 195 | 38 | 5 | 2444_DN | |
| Drug | Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; PC3; HT_HG-U133A | 1.75e-05 | 195 | 38 | 5 | 5077_DN | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A | 1.79e-05 | 196 | 38 | 5 | 3745_UP | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 1.79e-05 | 196 | 38 | 5 | 2236_DN | |
| Drug | phenformin hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 1.83e-05 | 197 | 38 | 5 | 21_UP | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.88e-05 | 198 | 38 | 5 | 3292_DN | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; HL60; HT_HG-U133A | 1.88e-05 | 198 | 38 | 5 | 2724_DN | |
| Drug | Cisapride [81098-60-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.88e-05 | 198 | 38 | 5 | 3305_DN | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; PC3; HT_HG-U133A | 1.88e-05 | 198 | 38 | 5 | 5095_UP | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; HL60; HT_HG-U133A | 1.88e-05 | 198 | 38 | 5 | 2206_UP | |
| Drug | Arcaine sulfate [14923-17-2]; Up 200; 14.8uM; HL60; HT_HG-U133A | 1.88e-05 | 198 | 38 | 5 | 3010_UP | |
| Drug | alizarin red S | 1.88e-05 | 95 | 38 | 4 | CID000008534 | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; HL60; HT_HG-U133A | 1.93e-05 | 199 | 38 | 5 | 2404_DN | |
| Drug | exemestane; Up 200; 0.01uM; MCF7; HG-U133A | 1.93e-05 | 199 | 38 | 5 | 165_UP | |
| Drug | Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.93e-05 | 199 | 38 | 5 | 2713_DN | |
| Drug | AC1Q5ZRG | 2.95e-05 | 36 | 38 | 3 | CID000004526 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.70e-04 | 167 | 38 | 4 | 3979_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.90e-04 | 172 | 38 | 4 | 4112_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 1.99e-04 | 174 | 38 | 4 | 5580_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.12e-04 | 177 | 38 | 4 | 3227_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Up 200; 11.4uM; PC3; HT_HG-U133A | 2.21e-04 | 179 | 38 | 4 | 4541_UP | |
| Drug | Metergoline [17692-51-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.41e-04 | 183 | 38 | 4 | 3221_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 10000uM; MCF7; HG-U133A | 2.67e-04 | 188 | 38 | 4 | 345_DN | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; PC3; HT_HG-U133A | 2.78e-04 | 190 | 38 | 4 | 5786_UP | |
| Drug | Prednisolone [50-24-8]; Up 200; 11uM; HL60; HT_HG-U133A | 2.83e-04 | 191 | 38 | 4 | 2393_UP | |
| Drug | Etofenamate [30544-47-9]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.89e-04 | 192 | 38 | 4 | 4108_UP | |
| Drug | Flunisolide [3385-03-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 2.89e-04 | 192 | 38 | 4 | 4303_UP | |
| Drug | Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.95e-04 | 193 | 38 | 4 | 5024_DN | |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; PC3; HT_HG-U133A | 2.95e-04 | 193 | 38 | 4 | 1817_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 4134_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 3747_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 3969_DN | |
| Drug | Dipyrone [5907-38-0]; Up 200; 12uM; PC3; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 4310_UP | |
| Drug | Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; HL60; HG-U133A | 3.01e-04 | 194 | 38 | 4 | 1556_UP | |
| Drug | Glipizide [29094-61-9]; Up 200; 9uM; MCF7; HT_HG-U133A | 3.07e-04 | 195 | 38 | 4 | 4991_UP | |
| Drug | rapamycin, Streptomyces hygroscepicus; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.07e-04 | 195 | 38 | 4 | 5980_DN | |
| Drug | Clioquinol [130-26-7]; Down 200; 13uM; HL60; HT_HG-U133A | 3.07e-04 | 195 | 38 | 4 | 3084_DN | |
| Drug | CAY10397; Up 200; 10uM; PC3; HT_HG-U133A | 3.07e-04 | 195 | 38 | 4 | 7087_UP | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; PC3; HT_HG-U133A | 3.07e-04 | 195 | 38 | 4 | 4660_DN | |
| Drug | GW8510; Up 200; 10uM; PC3; HT_HG-U133A | 3.07e-04 | 195 | 38 | 4 | 7085_UP | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; HL60; HT_HG-U133A | 3.07e-04 | 195 | 38 | 4 | 2708_DN | |
| Drug | Cyanocobalamin [68-19-9]; Up 200; 3uM; MCF7; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 3252_UP | |
| Drug | Boldine [476-70-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 4122_DN | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; PC3; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 3763_UP | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 6263_DN | |
| Drug | Estropipate [7280-37-7]; Down 200; 9.2uM; PC3; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 4472_DN | |
| Drug | Harpagoside [19210-12-9]; Down 200; 8uM; HL60; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 2935_DN | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; HL60; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 1864_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; MCF7; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 3604_UP | |
| Drug | Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 5007_DN | |
| Drug | valinomycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 5962_DN | |
| Drug | Edrophonium chloride [116-38-1]; Up 200; 19.8uM; HL60; HG-U133A | 3.13e-04 | 196 | 38 | 4 | 2019_UP | |
| Drug | Enoxacin [74011-58-8]; Down 200; 12.4uM; PC3; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 4655_DN | |
| Drug | Ketoprofen [22071-15-4]; Up 200; 15.8uM; PC3; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 3729_UP | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 7183_DN | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 4366_DN | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; HL60; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 3118_DN | |
| Drug | Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 6673_DN | |
| Drug | Procarbazine hydrochloride [366-70-1]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 3533_DN | |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Down 200; 13.6uM; HL60; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 2141_DN | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; HL60; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 2554_DN | |
| Drug | Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 4190_DN | |
| Drug | Piromidic acid [19562-30-2]; Down 200; 13.8uM; PC3; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 4575_DN | |
| Drug | rapamycin; Down 200; 0.1uM; MCF7; HG-U133A | 3.19e-04 | 197 | 38 | 4 | 326_DN | |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; PC3; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 4658_DN | |
| Drug | Chlorpropamide [94-20-2]; Down 200; 14.4uM; PC3; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 6291_DN | |
| Drug | Ramipril [87333-19-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 3572_DN | |
| Drug | PF-00539745-00 [351321-33-0]; Up 200; 10uM; PC3; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 5939_UP | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 2307_DN | |
| Drug | Clebopride maleate [84370-95-6]; Up 200; 8.2uM; PC3; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 6311_UP | |
| Drug | Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; HL60; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 2532_DN | |
| Drug | Colistin sulfate [1264-72-8]; Down 200; 3uM; HL60; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 2491_DN | |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 3415_DN | |
| Drug | Ungerine nitrate; Down 200; 10.2uM; HL60; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 2514_DN | |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; HL60; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 2177_UP | |
| Drug | Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 4974_DN | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 6663_DN | |
| Drug | alpha-Santonin [481-06-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 3877_DN | |
| Drug | Arecoline hydrobromide [300-08-3]; Up 200; 17uM; HL60; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 1303_UP | |
| Drug | Minaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 1468_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 1541_DN | |
| Drug | Mephenytoin [50-12-4]; Down 200; 18.4uM; PC3; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 5801_DN | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; PC3; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 5735_DN | |
| Drug | LY294002; Down 200; 10uM; SKMEL5; HG-U133A | 3.25e-04 | 198 | 38 | 4 | 501_DN | |
| Drug | Benzbromarone [3562-84-3]; Down 200; 9.4uM; HL60; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 1291_DN | |
| Drug | nocodazole; Down 200; 1uM; MCF7; HG-U133A | 3.25e-04 | 198 | 38 | 4 | 621_DN | |
| Drug | Nitrendipine [39562-70-4]; Down 200; 11uM; PC3; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 6304_DN | |
| Drug | Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; HL60; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 2492_UP | |
| Drug | Doxycycline hydrochloride [10592-13-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 3479_UP | |
| Drug | Flutamide [13311-84-7]; Up 200; 14.4uM; HL60; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 2358_UP | |
| Drug | Oxyphenbutazone [129-20-4]; Up 200; 12.4uM; HL60; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 6160_UP | |
| Drug | Biotin [58-85-5]; Down 200; 16.4uM; HL60; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 2428_DN | |
| Drug | Bromopride [4093-35-0]; Down 200; 11.6uM; HL60; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 2182_DN | |
| Drug | Equilin [474-86-2]; Down 200; 15uM; PC3; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 4659_DN | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 5793_DN | |
| Drug | Azapropazone [13539-59-8]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 6522_UP | |
| Drug | Metronidazole [443-48-1]; Up 200; 23.4uM; PC3; HG-U133A | 3.25e-04 | 198 | 38 | 4 | 1921_UP | |
| Disease | cardiovascular disease | 2.53e-04 | 457 | 37 | 5 | EFO_0000319 | |
| Disease | acute lymphoblastic leukemia, response to antineoplastic agent | 2.58e-04 | 19 | 37 | 2 | EFO_0000220, GO_0097327 | |
| Disease | asthma (is_marker_for) | 5.31e-04 | 126 | 37 | 3 | DOID:2841 (is_marker_for) | |
| Disease | FEV/FEC ratio | 7.31e-04 | 1228 | 37 | 7 | EFO_0004713 | |
| Disease | Rheumatoid Arthritis | 1.35e-03 | 174 | 37 | 3 | C0003873 | |
| Disease | adipose tissue measurement | 1.46e-03 | 45 | 37 | 2 | EFO_0004764 | |
| Disease | optic disc size measurement | 2.16e-03 | 205 | 37 | 3 | EFO_0004832 | |
| Disease | pulmonary hypertension (is_marker_for) | 2.94e-03 | 64 | 37 | 2 | DOID:6432 (is_marker_for) | |
| Disease | keratoconus | 3.12e-03 | 66 | 37 | 2 | MONDO_0015486 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 4.55e-03 | 80 | 37 | 2 | DOID:6432 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AVAFPHPRPFLASPP | 366 | Q8N350 | |
| AVSPVFFQLPAPHPP | 6 | Q5TEZ4 | |
| HESTPVNSFPPPFIE | 321 | P17405 | |
| PPVPTASSRFHFPPL | 141 | P41162 | |
| FTEEPPELPANSPHP | 676 | P51793 | |
| NHPPEDPFGSVPFIS | 671 | Q9NSY1 | |
| FAPSPTLPPTFHPEE | 776 | Q5TC82 | |
| FPSHLFLEQRSPPPP | 471 | Q96EV2 | |
| DHPPPPESKIQSFFG | 331 | Q96NA2 | |
| APTFPTPNTDIFPEP | 206 | P18146 | |
| SLPEPHPGPDFFIPL | 21 | Q9BZM3 | |
| HPEPFTPPSSPQVGF | 886 | Q9H6R4 | |
| SELPFPSHVLPEPGF | 1451 | Q9P1Y6 | |
| PSHVLPEPGFPDTDP | 1456 | Q9P1Y6 | |
| PPPPPHRDFISVTLS | 41 | Q9UKM7 | |
| PSEEPFPSVRPFPSV | 801 | P16112 | |
| PFPSVELFPSEEPFP | 811 | P16112 | |
| HFPPPPPILETSSLE | 561 | Q8WX93 | |
| ASPHLFTFPPTPPKD | 146 | P23771 | |
| PPPPHFSETFPSLPA | 166 | Q14549 | |
| NIHFPSPLPTPLDPE | 251 | Q6UUV9 | |
| FPPPDTTPLSPPHSF | 131 | Q13873 | |
| TDLDSFVAFHPPLPP | 746 | Q9P203 | |
| SHPDPAFSIFPPDAP | 571 | Q12770 | |
| LVTSTHFPPEPGPPE | 336 | Q9BT04 | |
| EEPLHLFFAPPSPPN | 276 | O75677 | |
| FPSDFPTEPPSLPRT | 1586 | Q02880 | |
| IPVGPPSPFPTSEDF | 46 | Q9HAZ2 | |
| EAFPPPPHFSFPAPL | 1266 | Q9Y2G9 | |
| HFPPPPEEPTATAAF | 406 | Q9UPS6 | |
| SSDPPPAFSVFCHPP | 216 | Q66K80 | |
| PPPEFEFIADPPSIS | 146 | Q15459 | |
| EEHPAPEVSTPFPPL | 486 | Q8TE77 | |
| DTPAPPTPTGPFDFA | 71 | Q6UX72 | |
| SSFTHCRPPLDPEPP | 501 | Q96RK0 | |
| DPEIAAETPPPPHAS | 621 | G9CGD6 | |
| VGLLPTPPEHFPFSD | 396 | P61129 | |
| PLTFPTLDDFIPPHL | 201 | Q9BX66 | |
| LSVFPLPSHPAAPPE | 71 | Q8N5T2 | |
| ETFPSDPPEPLPHFL | 51 | O95185 | |
| FPLFLEPPSSHVSPS | 1156 | Q9H2Y7 | |
| LSVPSPPPDPDSFFT | 161 | O15069 |